MGRX Mangoceuticals, Inc.
Mangoceuticals, Inc. operates in the Services-Misc Health & Allied Services, Nec industry.
On the WireNo stories on MGRX yet. Follow the company and the next one lands in Following.
The numbers · FY2025, filed
SEC EDGARAll filed figures
Snapshot
SEC EDGAR · FY 2025-12-31Revenue by fiscal year
Operating leverage — margins
Financials, annual · income and cash flowSEC EDGAR · open ▸
Financials — annual
SEC EDGAR · last 4 FY · tap a row to explain it| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $8,939 | $731,493 | $615,873 | $456,021 |
| Gross Profit | $4,850 | $431,501 | $379,964 | $250,386 |
| Operating Income | $-2.0M | $-9.2M | $-8.0M | $-18.0M |
| Net Income | $-2.0M | $-9.2M | $-8.7M | $-20.6M |
| Diluted EPS | $-0.19 | $-8.58 | $-4.80 | $-2.17 |
| Operating Cash Flow | $-1.3M | $-7.0M | $-4.9M | $-5.9M |
| Free Cash Flow | $-1.4M | $-7.0M | — | — |
Same industry
In the screener →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.